Marietta Charakida



  1. Charakida M, Loukogeorgakis S, Okorie M, Masi S, Halcox J, Deanfield J, et al. Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy. Antivir Ther. 2009;14:1075-9 pubmed publisher
    ..HIV-infected children have increased arterial stiffness compared with healthy children. These changes were more pronounced with increasing age in HIV-infected children particularly in those who were receiving ART. ..
  2. request reprint
    Charakida M, Tousoulis D. Infections and atheromatous plaque: current therapeutic implications. Curr Pharm Des. 2013;19:1638-50 pubmed
    ..Efforts to prevent infection with vaccination or treat specific infectious agents with antibiotics have provided mostly negative results, thereby challenging the validity of the infectious hypothesis of atherosclerosis. ..
  3. Charakida M, Jones A, Falaschetti E, Khan T, Finer N, Sattar N, et al. Childhood obesity and vascular phenotypes: a population study. J Am Coll Cardiol. 2012;60:2643-50 pubmed publisher
    ..This could represent physiological adaptation to the hyperemic state of adiposity in childhood. ..
  4. Charakida M, Besler C, Batuca J, Sangle S, Marques S, Sousa M, et al. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA. 2009;302:1210-7 pubmed publisher
    ..In patients with aPL, HDL reduced nitric oxide bioavailability and had impaired anti-inflammatory and antioxidant properties. ..
  5. request reprint
    Charakida M, O Neil F, Masi S, Papageorgiou N, Tousoulis D. Inflammatory disorders and atherosclerosis: new therapeutic approaches. Curr Pharm Des. 2011;17:4111-20 pubmed
    ..Further longitudinal studies are required to assess the value of different therapeutic approaches on cardiovascular outcome of these patients. ..